193201 | 193201 | Phase II Study of Growth Hormone in Children With Cystic Fibrosis | Completed | No Results Available | Cystic Fibrosis | Drug: growth hormone | https://ClinicalTrials.gov/show/NCT00016445 |
193202 | 193202 | Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen | Completed | No Results Available | Breast Cancer | Drug: exemestane|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00016432 |
193203 | 193203 | S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome | Completed | No Results Available | Leukemia|Myelodysplastic Syndromes | Biological: anti-thymocyte globulin|Drug: cyclosporine | https://ClinicalTrials.gov/show/NCT00016419 |
193204 | 193204 | S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer | Completed | No Results Available | Breast Cancer | Biological: filgrastim|Drug: cyclophosphamide|Drug: doxorubicin|Drug: paclitaxel|Procedure: surgery | https://ClinicalTrials.gov/show/NCT00016406 |
193205 | 193205 | BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | Completed | No Results Available | Prostate Cancer | Drug: ixabepilone | https://ClinicalTrials.gov/show/NCT00016393 |
193206 | 193206 | Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen | Completed | No Results Available | Cancer | Drug: dexamethasone|Drug: ondansetron|Procedure: quality-of-life assessment | https://ClinicalTrials.gov/show/NCT00016380 |
193207 | 193207 | Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Completed | No Results Available | Lung Cancer | Biological: Trastuzumab|Drug: Cisplatin|Drug: Gemcitabine Hydrochloride | https://ClinicalTrials.gov/show/NCT00016367 |
193208 | 193208 | Benzoylphenylurea in Treating Patients With Advanced Solid Tumors | Completed | Has Results | Unspecified Adult Solid Tumor, Protocol Specific | Drug: benzoylphenylurea | https://ClinicalTrials.gov/show/NCT00016354 |
193209 | 193209 | Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | Terminated | No Results Available | Endometrial Cancer | Biological: filgrastim|Drug: cisplatin|Drug: doxorubicin hydrochloride|Drug: megestrol acetate|Drug: paclitaxel|Drug: tamoxifen citrate | https://ClinicalTrials.gov/show/NCT00016341 |
193210 | 193210 | CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme | Completed | No Results Available | Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor | Drug: temsirolimus|Other: laboratory biomarker analysis|Other: pharmacological study | https://ClinicalTrials.gov/show/NCT00016328 |
193211 | 193211 | Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer | Completed | No Results Available | Lung Cancer | Drug: carboplatin|Drug: gemcitabine hydrochloride|Drug: paclitaxel|Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00016315 |
193212 | 193212 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | Completed | No Results Available | T-cell Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia | Drug: prednisone|Drug: vincristine sulfate|Drug: daunorubicin hydrochloride|Drug: asparaginase|Drug: methotrexate|Drug: cyclophosphamide|Drug: cytarabine|Drug: mercaptopurine|Drug: leucovorin calcium|Drug: dexamethasone|Drug: doxorubicin hydrochloride|Drug: thioguanine|Radiation: radiation therapy|Drug: nelarabine|Drug: pegaspargase|Radiation: radiation therapy|Other: pharmacological study|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00016302 |
193213 | 193213 | Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer | Completed | No Results Available | Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer | Biological: recombinant interleukin-12 | https://ClinicalTrials.gov/show/NCT00016289 |
193214 | 193214 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | Terminated | No Results Available | Cardiac Toxicity|Inflammatory Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer | Drug: dexrazoxane hydrochloride|Drug: doxorubicin hydrochloride|Drug: cyclophosphamide|Drug: paclitaxel|Biological: trastuzumab|Procedure: therapeutic conventional surgery|Radiation: radiation therapy|Drug: tamoxifen citrate|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00016276 |
193215 | 193215 | Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma | Completed | No Results Available | Melanoma (Skin) | Biological: oblimersen sodium|Drug: dacarbazine | https://ClinicalTrials.gov/show/NCT00016263 |
193216 | 193216 | Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer | Completed | No Results Available | Colorectal Cancer | Drug: MKC-1 | https://ClinicalTrials.gov/show/NCT00016250 |
193217 | 193217 | Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment | Completed | No Results Available | Bladder Cancer|Kidney Cancer|Lung Cancer | Biological: tucotuzumab celmoleukin | https://ClinicalTrials.gov/show/NCT00016237 |
193218 | 193218 | Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian Cancer | Completed | No Results Available | Ovarian Cancer | Drug: thalidomide | https://ClinicalTrials.gov/show/NCT00016224 |
193219 | 193219 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | Completed | No Results Available | Lung Cancer | Radiation: radiation therapy | https://ClinicalTrials.gov/show/NCT00016211 |
193220 | 193220 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | Completed | No Results Available | Colorectal Cancer | Drug: FOLFOX regimen|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatin | https://ClinicalTrials.gov/show/NCT00016198 |
193221 | 193221 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | Completed | No Results Available | Unspecified Adult Solid Tumor, Protocol Specific | Drug: alvocidib|Drug: docetaxel | https://ClinicalTrials.gov/show/NCT00016185 |
193222 | 193222 | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma | Completed | No Results Available | Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific | Drug: pegylated liposomal doxorubicin hydrochloride|Drug: picoplatin | https://ClinicalTrials.gov/show/NCT00016172 |
193223 | 193223 | Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia | Completed | No Results Available | Leukemia | Biological: filgrastim|Biological: lintuzumab|Drug: arsenic trioxide|Drug: idarubicin|Drug: tretinoin | https://ClinicalTrials.gov/show/NCT00016159 |
193224 | 193224 | Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | Completed | No Results Available | Prostate Cancer | Biological: GPI-0100|Biological: MUC-2-Globo H-KLH conjugate vaccine | https://ClinicalTrials.gov/show/NCT00016146 |
193225 | 193225 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | Completed | No Results Available | Colorectal Cancer | Biological: BCG vaccine|Biological: autologous tumor cell vaccine|Drug: fluorouracil|Drug: leucovorin calcium|Procedure: adjuvant therapy | https://ClinicalTrials.gov/show/NCT00016133 |
193226 | 193226 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer | Completed | No Results Available | Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer | Drug: estramustine phosphate sodium|Drug: docetaxel|Biological: bevacizumab|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00016107 |
193227 | 193227 | S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma | Completed | No Results Available | Anaplastic Large Cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma | Biological: bevacizumab|Other: laboratory biomarker analysis | https://ClinicalTrials.gov/show/NCT00016094 |
193228 | 193228 | Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation | Completed | No Results Available | Infection | Drug: ribavirin | https://ClinicalTrials.gov/show/NCT00016081 |
193229 | 193229 | Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation | Completed | No Results Available | Infection | Drug: ganciclovir|Drug: valganciclovir | https://ClinicalTrials.gov/show/NCT00016068 |
193230 | 193230 | Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma | Active, not recruiting | No Results Available | Melanoma (Skin) | Biological: lymphokine-activated killer cells|Drug: temozolomide | https://ClinicalTrials.gov/show/NCT00016055 |